Galmed to acquire Colospan for $4.5 million in medical device deal
Tweet Send to a Friend
Galmed Pharmaceuticals Ltd. (NASDAQ: GLMD) announced it has entered into a definitive agreement to acquire Colospan Ltd., a medical device ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


